Drug Discovery 2012 and Beyond

ADVERTISEMENT RETURN TO ISSUEPREVViewpointNEXTDrug Discovery 2012 and BeyondDavid P. Rotella*View Author Information Margaret and Herman Sokol Professor of Chemistry, Department of Chemistry and Biochemistry, Sokol Institute for Pharmaceutical Life Sciences, Montclair State University, 1 Normal Avenue, Montclair, New Jersey 07043, United StatesCite this: ACS Med. Chem. Lett. 2012, 3, 3, 172–173Publication Date (Web):January 31, 2012Publication History Published online31 January 2012Published inissue 8 March 2012https://pubs.acs.org/doi/10.1021/ml300022phttps://doi.org/10.1021/ml300022peditorialACS PublicationsCopyright © 2012 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views9505Altmetric-Citations6LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (133 KB) Get e-AlertscloseSUBJECTS:Cancer therapy,Drug discovery,Molecular modeling,Pharmaceuticals Get e-Alerts